Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Truist Financial Corp

Truist Financial Corp grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.3% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 256,292 shares of the medical equipment provider’s stock after acquiring an additional 8,200 shares during the quarter. Truist Financial Corp’s holdings in Intuitive Surgical were worth $126,934,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of ISRG. Atala Financial Inc acquired a new position in shares of Intuitive Surgical during the 4th quarter valued at about $25,000. Parvin Asset Management LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter valued at about $26,000. Global Financial Private Client LLC increased its position in Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock worth $26,000 after purchasing an additional 38 shares in the last quarter. Hurley Capital LLC acquired a new stake in Intuitive Surgical during the 4th quarter worth approximately $28,000. Finally, Summit Securities Group LLC acquired a new stake in Intuitive Surgical during the 4th quarter worth approximately $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of research analyst reports. Piper Sandler dropped their target price on shares of Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating for the company in a research report on Wednesday, April 23rd. Royal Bank Of Canada dropped their target price on shares of Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a research report on Wednesday, April 23rd. BTIG Research set a $560.00 target price on shares of Intuitive Surgical and gave the stock a “buy” rating in a research report on Monday, April 14th. Deutsche Bank Aktiengesellschaft downgraded shares of Intuitive Surgical from a “hold” rating to a “sell” rating and dropped their target price for the stock from $515.00 to $440.00 in a research report on Monday, June 9th. Finally, Truist Financial dropped their target price on shares of Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a research report on Wednesday, April 23rd. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $588.95.

Intuitive Surgical Stock Up 0.6%

Shares of NASDAQ:ISRG opened at $543.74 on Friday. Intuitive Surgical, Inc. has a 52-week low of $413.82 and a 52-week high of $616.00. The company has a 50 day moving average of $537.11 and a two-hundred day moving average of $536.76. The company has a market capitalization of $194.89 billion, a price-to-earnings ratio of 79.73, a price-to-earnings-growth ratio of 5.78 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. The company had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same period in the prior year, the business posted $1.50 EPS. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insiders Place Their Bets

In other news, EVP Gary Loeb sold 1,700 shares of the stock in a transaction that occurred on Friday, April 25th. The stock was sold at an average price of $513.18, for a total transaction of $872,406.00. Following the completion of the transaction, the executive vice president directly owned 2,245 shares in the company, valued at approximately $1,152,089.10. This represents a 43.09% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Robert Desantis sold 188 shares of the stock in a transaction that occurred on Monday, April 28th. The shares were sold at an average price of $515.91, for a total value of $96,991.08. Following the transaction, the executive vice president owned 5,224 shares of the company’s stock, valued at approximately $2,695,113.84. This trade represents a 3.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 4,998 shares of company stock valued at $2,611,577. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.